WeVote

Bill

Bill

SB 647

authorizing the department of insurance to participate in a cooperative procurement group via an intergovernmental agreement for a prescription drug discount program.

2026 Regular Session Introduced by Kevin Avard and 5 co-sponsors

SB 647 allows New Hampshire's insurance department to join a multi-state drug discount cooperative to negotiate lower prescription medication prices for residents.

Refer for Interim Study: MA VV 05/14/2026 HJ 13
0
WeVote Research Nonpartisan
Bill Summary · SB 647

Legislative bill overview

SB 647 authorizes New Hampshire's Department of Insurance to join a cooperative procurement group through an intergovernmental agreement to offer a prescription drug discount program. The bill enables the state to leverage group purchasing power to negotiate lower drug prices for participating individuals and entities.

Why is this important

Prescription drug costs are a significant burden for many consumers and state budgets. By joining a cooperative purchasing group, New Hampshire could potentially reduce medication expenses for residents while expanding access to affordable pharmaceuticals. This represents a cost-containment strategy that multiple states have adopted with varying degrees of success.

Potential points of contention

  • Program design and oversight: The bill's reliance on an intergovernmental agreement leaves specifics about eligibility, discount levels, and program administration to be determined later, creating uncertainty about actual savings and coverage
  • Insurance market impacts: Participating insurers and pharmacy benefit managers may resist programs that reduce their negotiating leverage or alter existing discount arrangements
  • Fiscal responsibility and liability: Questions remain about state liability if the cooperative underperforms, whether taxpayers subsidize shortfalls, and whether savings justify administrative costs

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.